Hangzhou Tigermed Consulting Co Ltd - Class A

SZSE:300347 (China)   Class A
¥ 45.20 (+0.33%) Mar 1
17.11
P/B:
1.86
Market Cap:
¥ 36.95B ($ 5.13B)
Enterprise V:
¥ 33.20B ($ 4.61B)
Volume:
11.81M
Avg Vol (2M):
13.85M
Also Trade In:
Volume:
11.81M
Avg Vol (2M):
13.85M

Business Description

Description
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Hangzhou Tigermed Consulting Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 7,329.931
EPS (TTM) (¥) 2.63
Beta 1.62
Volatility % 38.07
14-Day RSI 50.49
14-Day ATR (¥) 2.12193
20-Day SMA (¥) 42.752
12-1 Month Momentum % -63.99
52-Week Range (¥) 36.12 - 116.72
Shares Outstanding (Mil) 872.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hangzhou Tigermed Consulting Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Hangzhou Tigermed Consulting Co Ltd Stock Events

Financials Calendars
Event Date Price(¥)
No Event Data

Hangzhou Tigermed Consulting Co Ltd Frequently Asked Questions

What is Hangzhou Tigermed Consulting Co Ltd(SZSE:300347)'s stock price today?
The current price of SZSE:300347 is ¥45.20. The 52 week high of SZSE:300347 is ¥116.72 and 52 week low is ¥36.12.
When is next earnings date of Hangzhou Tigermed Consulting Co Ltd(SZSE:300347)?
The next earnings date of Hangzhou Tigermed Consulting Co Ltd(SZSE:300347) is .
Does Hangzhou Tigermed Consulting Co Ltd(SZSE:300347) pay dividends? If so, how much?
The  Dividend Yield %  of Hangzhou Tigermed Consulting Co Ltd(SZSE:300347) is 1.22% (As of Today), Highest Dividend Payout Ratio of Hangzhou Tigermed Consulting Co Ltd(SZSE:300347) was 0.64. The lowest was 0.21. And the median was 0.31. The  Forward Dividend Yield % of Hangzhou Tigermed Consulting Co Ltd(SZSE:300347) is 1.22%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release